Zdrowie i gospodarka · 23/10/2003

FDA Announces Draft Guidance on Marketed Unapproved Drugs

The Food and Drug Administration (FDA) has released a draft guidance document outlining its approach to enforcing regulations on unapproved drugs sold in the US market, which will eventually replace a section of its Compliance Policy Guide.